Should heart health get more attention in WM patients?
About 8% of patients with the slow-growing Waldenström macroglobulinemia (WM) died from cardiovascular diseases – not their cancer – between 1999-2000, raising questions
About 8% of patients with the slow-growing Waldenström macroglobulinemia (WM) died from cardiovascular diseases – not their cancer – between 1999-2000, raising questions
Simu Du, MD, an internal medicine resident at the Jacobi Medical Center, affiliated with Albert Einstein College of Medicine in the Bronx, shares
The Board of Directors and the Steering Committee of the Society of Hematologic Oncology (SOHO) are pleased to announce that John DiPersio, MD,
In addition to death and taxes, no academic faculty member can escape the judgment of the dreaded Appointment and Promotions (A&P) Committee. In
Megan Melody, MD, is an assistant professor at the University of South Florida and lymphoma and CAR T-cell therapy specialist at Tampa General Hospital Cancer
This is a special year, as SOHO has surpassed the 10,000-member milestone, which is incredible considering the society is just over 10 years
Thomas G. Martin, MD, of the University of California, San Francisco, and Robert Orlowski, MD, PhD, of the University of Texas MD Anderson
We have very good speakers and some really interesting topics at this year’s CLL session. The session opens with Dr. Lydia Scarfò’s presentation
The Society of Hematologic Oncology (SOHO) announced the abstract award winners of its 13th Annual Meeting at Wednesday evening’s award ceremony, presenting eight
The myeloproliferative neoplasms (MPNs) session this morning will bring together a full spectrum of timely topics, from novel therapies in polycythemia vera (PV)